Skip to main content

Teresa Moline Marimon

Institutions of which they are part

Research technician
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Teresa Moline Marimon

Institutions of which they are part

Research technician
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Estudio de la cooperación clonal (heterogeneidad intratumoral) in vitro e in vivo en carcinomas: papel de los exosomas y estudio de los factores secretados

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Teresa Moline Marimon, Josep Castellví Vives, Stefan Hummer
Funding agency: Instituto de Salud Carlos III
Funding: 123420
Reference: PI17/02247
Duration: 01/01/2018 - 31/12/2020

Efectos bifásicos y formas truncadas de la Cx43 en cáncer de mama: aplicaciones pronósticas y terapéuticas

IP: Trond Aasen
Collaborators: Jordi Temprana Salvador, Teresa Moline Marimon, Marta Sese Faustino
Funding agency: Instituto de Salud Carlos III
Funding: 92565
Reference: PI16/00772
Duration: 01/01/2017 - 30/06/2021

Nuevas estrategias terapéuticas para el cáncer de mama: uso de inhibidores de las MNKs y caracterización de nuevos factores que confieren resistencia al estrés celular.

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Jordi Temprana Salvador, Roso Marès Pagès, Teresa Moline Marimon, Josep Castellví Vives, Maria Teresa Salcedo Allende, Marta Sese Faustino
Funding agency: Instituto de Salud Carlos III
Funding: 272552.5
Reference: PI14/01320
Duration: 01/01/2015 - 31/03/2018

Identificación de nuevos factores pronóstico y diagnóstico en cáncer basados en microRNAs y sus proteínas diana que se asocian a tumores de carácter más agresivo

IP: Matilde Lleonart Pajarin
Collaborators: Angel García Jiménez, Teresa Moline Marimon, Carmela Iglesias i Felip, Vicente Peg Camara
Funding agency: Instituto de Salud Carlos III
Funding: 145200
Reference: PI12/01104
Duration: 01/01/2013 - 30/06/2017

Related news

On World Cancer Research Day, we highlight the oncology research model of the Vall d'Hebron Campus that allows laboratory results to be transferred as quickly as possible to clinical practice.

Vall d’Hebron ha celebrat avui la Jornada del Dia Mundial contra el Càncer, una malaltia cada cop més freqüent que patiran al llarg de la vida un de cada dos homes i una de cada tres dones del nostre entorn.

The multidisciplinary paper on papillary thyroid cancer has been considered the best original article of 2021 in the journal Endocrinología, Diabetes y Nutrición

Related professionals

Olga Luengo Sanchez

Olga Luengo Sanchez

Systemic Diseases
Read more
Gerard Oristrell Santamaria

Gerard Oristrell Santamaria

Predoctoral researcher
Cardiovascular Diseases
Read more
Miriam Asensio Tapias

Miriam Asensio Tapias

Research technician
Biomedical Research in Gynaecology
Read more
Sebastian Lazaro

Sebastian Lazaro

Research technician
Genetics Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.